Is it growing?
Is ACAD growing?
ACADIA Pharmaceuticals Inc. has grown revenue 28% a year over three years and 19% a year over five.
+28%
Revenue growth, 3-year annual rate · Biotechnology median +21% · compounding fast · compounded from trailing twelve-month revenue
- Revenue growth, 5-year rate
- +19%
Revenue growth, 5-year rate · +28% over three · growth has picked up over the last three years
- Years of annual history on file
- 17
Years of annual history on file · FY2009 to FY2025, as filed
Details›
- Revenue FY2021
- $484M
- Revenue FY2022
- $517M
- Revenue FY2023
- $726M
- Revenue FY2024
- $958M
- Revenue FY2025
- $1.07B
Annual income statements as filed with the SEC.